share_log

佐力药业:关于公司高级管理人员收到浙江证监局监管谈话措施决定的公告

Zhejiang Jolly Pharmaceutical: Notice on the company's senior management receiving the Zhejiang Securities Regulatory Bureau's regulatory dialogue measures decision

SZSI ·  Apr 30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more